Skip to content
Screener

Xeris Biopharma Holdings, Inc. XERS Concentration Risk %

Concentration Risk % at other companies

Burlington Stores logo
Burlington StoresBURL
5%0.0pp
Burlington Stores logo
Burlington StoresBURL
0.8%0.0pp
Ulta Beauty, Inc. logo
Ulta Beauty, Inc.ULTA
40%0.0pp
Ulta Beauty, Inc. logo
Ulta Beauty, Inc.ULTA
4%0.0pp
Ulta Beauty, Inc. logo
Ulta Beauty, Inc.ULTA
24%-1.0pp
Expro Group Holdings logo
Expro Group HoldingsXPRO
4.8%+0.4pp

Other financials

Income statement

See full
Revenue$92.1M+28.7%
Gross profit$79.6M+33.4%
Operating income$5.2M+15.4%
Net income-$31.1M-1,513%
EPS (diluted)-$0.18-1,700%

Balance sheet

See full
Cash & equivalents$121.7M+105%
Total debt$289.4M+12.5%
Total equity-$9.7M+49.6%
Total assets$411.9M+23.1%

Cash flow

See full
Operating cash flow$8.3M+4,440%
CapEx$131.0K—
Free cash flow-$29.1M—

Valuation

See full
Market cap$1.27B+24.4%
Enterprise value$1.44B+18.6%
P/S3.8×-0.4×

Profitability

See full
Gross margin86.6%+4.3pp
Operating margin10.9%+8.4pp
Net margin-5.1%-1.9pp

Returns & leverage

See full
Return on equity-209.8%—
Debt / equity19.9×—
Current ratio1.4×-0.5×